En español
NIDA

Researchers

Regular marijuana users may have impaired brain reward centers

New research shows that regular marijuana users show impairments in the brain’s ability to respond to dopamine – a brain chemical that is involved in reward, among other functions.


NIH system to monitor emerging drug trends

An innovative National Drug Early Warning System (NDEWS) is being developed to monitor emerging trends that will help health experts respond quickly to potential outbreaks of illicit drugs such as heroin and to identify increased use of designer synthetic compounds.


New brain imaging dataset now available to enhance reliability and reproducibility

A new NIDA-supported dataset will now allow researchers to compare their MRI-based scans against more than 10,000 brain images, thereby enhancing reliability and reproducibility.


Study compares effectiveness of oral drug tests for recent marijuana use

A variety of oral drug testing devices are available to determine recent marijuana use. For the first time, a new NIDA study compares the ability of these devices to accurately detect specific cannabinoids – the chemical compounds found in marijuana.


CPDD conference features NIDA Director Dr. Nora Volkow as well as Media Forum

Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA), will deliver a keynote address on the state of addiction research at the annual meeting of the College on Problems of Drug Dependence (CPDD) in San Juan, Puerto Rico on June 15.


MDMA can be fatal in warm environments

A moderate dose of MDMA, commonly known as Ecstasy or Molly, that is typically nonfatal in cool, quiet environments can be lethal in rats exposed to conditions that mimic the hot, crowded, social settings where the drug is often used by people, a study


Pages

Subscribe to Researchers